GLP-1 and GIP receptor agonist formulations for subcutaneous administration in type 2 diabetes management. Employed in hospitals, outpatient clinics, and endocrinology practices by physicians and nurses. Procured by healthcare facilities from pharmaceutical manufacturers via wholesalers and distributors for patient therapy